Recruiting

Observational Study

Sponsor:

Yale University

Code:

NCT03792659

Conditions

Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Blood Sample Draw

Study Details

Brief summary:

The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.

Conditions

Myasthenia Gravis

Study ID

NCT03792659

Start date

Mar 30, 2016

Status verified date

Nov, 2025

Completion date

Oct 30, 2026

Anticipated

Primary completion date

Sep 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.

Exclusion Criteria:

  • Failure to meet the Inclusion Criteria.

Study Design

Enrollment

800 participants

Anticipated

Interventions and Outcome Measures

Arms

Neurological Outpatients

Participants in this group will be recruited from the outpatient clinical population at the Yale University Department of Neurology. Treating physicians will make the initial determination of patients' potential eligibility to participate in the study.

Interventions

Blood Sample Draw

Approximately 100 cc (less than 1/2 cup) of blood will be drawn from both groups.

Primary outcome measure

  • The number of successful blood draws will be reported at the conclusion of the sample collection [ Time Frame: 8 years ]

Central Contacts and Locations

Central contacts

Bailey Sheldon, PhD

203-737-7095bailey.munrosheldon@yale.edu

Locations

Yale-New Haven Hospital

Recruiting

New Haven, Connecticut, United States, 06510

Contacts

Bailey Munro Sheldon, PhD

203-737-7095bailey.munrosheldon@yale.edu

Principal Investigator:

Richard Nowak, MD, MS

More Information

Sponsor

Yale University

Last update posted

Nov 28, 2025

Last verified

Nov, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Yale University on 2025-11-28.